Hill Dermaceuticals
United States 60 employees Updated 9 July 2026
Hill Dermaceuticals is a finished-dose manufacturer based in United States. It appears in 19 regulatory filings across 6 regulators, without an active US DMF or CEP on file. Its filings concentrate with Health Canada, ARCSA (EC) and MINSA (CR). Its GMP standing is certified by US FDA. Its most recent recorded inspection, by US FDA, closed on 14 October 2025 as VAI.
2
registered plants
1 with an FDA FEI number
19
filings
across 6 regulators
These figures were checked against the regulators' own files on 25 July 2026
Inspections
8 of 8 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.
Inspection history
- 14 October 2025 VAI US FDA
- 11 August 2021 VAI US FDA
- 18 May 2018 VAI US FDA
- 6 October 2014 VAI US FDA
- 10 August 2012 OAI US FDA
- 30 March 2012 OAI US FDA
- 10 September 2010 OAI US FDA
- 19 February 2010 NAI US FDA
NAI means no action indicated, VAI means voluntary action indicated, and OAI means
official action indicated.
Registered plants
| Site | FDA FEI |
| Sanford, United Arab Emirates | Not on file |
| SANFORD, United States | 1036365 |
Filings and GMP by regulator
| Regulator | Filings | GMP certificates |
| Health Canada | 14 | None |
| ARCSA (EC) | 1 | None |
| MINSA (CR) | 1 | None |
| US FDA | 1 | 1 |
| EDE (AE) | 1 | None |
| NPRA (MY) | 1 | None |
Comparing suppliers?
Choose your molecules and target markets. Hill Dermaceuticals comes back tiered against every other
supplier able to file there.
Start for free No sales call.
Open risk flags
- The most recent inspection outcome was VAI, on 14 October 2025.
Sources on this page
- FDA
- Drug master files, establishment registration, inspection classifications
- EDQM
- Certificates of suitability
- EudraGMDP and national regulators
- GMP certificates